AAAAAA
Results: 1-25/40
Authors:
Gravis, G
Mousseau, M
Douillard, JY
Dorval, T
Fabbro, M
Escudier, B
Mignot, L
Viens, P
Citation: G. Gravis et al., Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial, EUR CYTOKIN, 12(2), 2001, pp. 239-243
Authors:
Ledermann, JA
Herd, R
Maraninchi, D
Viens, P
Buclon, M
Philip, T
Cure, H
Lotz, JP
Chauvin, F
Ferrante, P
Rosti, G
Citation: Ja. Ledermann et al., High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT), ANN ONCOL, 12(5), 2001, pp. 693-699
Authors:
Viens, P
Maraninchi, D
Citation: P. Viens et D. Maraninchi, Issues in biotherapy for cancer, BIOFUTUR, 2001(212), 2001, pp. 32-35
Authors:
Viens, P
Roche, H
Kerbrat, P
Fumoleau, P
Guastalla, JP
Delozier, T
Citation: P. Viens et al., Epirubicin-docetaxel combination in first-line chemotherapy for patients with metastatic breast cancer - Final results of a dose-finding and efficacystudy, AM J CL ONC, 24(4), 2001, pp. 328-335
Authors:
Goncalves, A
Camerlo, J
Bun, H
Gravis, G
Genre, D
Bertucci, F
Resbeut, M
Pech-Gourg, F
Durand, A
Maraninchi, D
Viens, P
Citation: A. Goncalves et al., Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: Clinical results and pharmacokinetics, ANTICANC R, 21(2B), 2001, pp. 1431-1437
Authors:
Pepin, J
Sobela, F
Deslandes, S
Alary, M
Wegner, K
Khonde, N
Kintin, F
Kamuragiye, A
Sylla, M
Zerbo, PJ
Baganizi, E
Kone, A
Kane, F
Masse, B
Viens, P
Frost, E
Citation: J. Pepin et al., Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichamonas vaginalis, B WHO, 79(2), 2001, pp. 118-126
Authors:
Diallo, AB
De Serres, G
Beavogui, AH
Lapointe, C
Viens, P
Citation: Ab. Diallo et al., Home care of malaria-infected children of less than 5 years of age in a rural area of the Republic of Guinea, B WHO, 79(1), 2001, pp. 28-32
Authors:
Viens, P
Maraninchi, D
Citation: P. Viens et D. Maraninchi, High-dose chemotherapy with hematopoietic stem-cell support in breast cancer, B CANCER, 88(9), 2001, pp. 835-841
Authors:
Bertucci, F
Houlgatte, R
Nguyen, C
Benziane, A
Nasser, V
Granjeaud, S
Tagett, B
Loriod, B
Giaconia, A
Jacquemier, J
Viens, P
Birnbaum, D
Citation: F. Bertucci et al., Molecular typing of breast cancer: transcriptomics and DNA microarrays, B CANCER, 88(3), 2001, pp. 277-286
Authors:
Chabannon, C
Olivero, S
Viret, F
Arnoulet, C
Sainty, D
Maraninchi, D
Viens, P
Citation: C. Chabannon et al., Detection of epithelial cells in hematopoietic organs of patients with breast cancer - Physiopathological significance and clinical consequences, ACT HAEMAT, 105(3), 2001, pp. 166-171
Authors:
Chabannon, C
Olivero, S
Blaise, D
Maraninchi, D
Viens, P
Citation: C. Chabannon et al., Ex vivo expansion of human hematopoietic progenitors and cells to support high-dose chemoradiation therapy: Five years of clinical experience, CYTOK CELL, 6(2), 2000, pp. 97-108
Authors:
Mathoulin-Portier, MP
Viens, P
Cowen, D
Bertucci, F
Houvenaeghel, G
Geneix, J
Puig, B
Bardou, VJ
Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin, ONCOL REP, 7(3), 2000, pp. 675-680
Authors:
Bertucci, F
Houlgatte, R
Benziane, A
Granjeaud, S
Adelaide, J
Tagett, R
Loriod, B
Jacquemier, J
Viens, P
Jordan, B
Birnbaum, D
Nguyen, C
Citation: F. Bertucci et al., Gene expression profiling of primary breast carcinomas using arrays of candidate genes, HUM MOL GEN, 9(20), 2000, pp. 2981-2991
Authors:
Protiere, C
Viens, P
Genre, D
Cowen, D
Camerlo, J
Gravis, G
Alzieu, C
Bertucci, F
Resbeut, M
Maraninchi, D
Moatti, JP
Citation: C. Protiere et al., Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer, ANN ONCOL, 11(1), 2000, pp. 39-45
Authors:
Macquart-Moulin, G
Viens, P
Palangie, T
Bouscary, ML
Delozier, T
Roche, H
Janvier, M
Fabbro, M
Moatti, JP
Citation: G. Macquart-moulin et al., High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on quality of life jeopardize feasibility and acceptability of treatment?, J CL ONCOL, 18(4), 2000, pp. 754-764
Authors:
Alexandre, J
Bleuzen, P
Bonneterre, J
Sutherland, W
Misset, JL
Guastalla, JP
Viens, P
Faivre, S
Chahine, A
Spielman, M
Bensmaine, A
Marty, M
Mahjoubi, M
Cvitkovic, E
Citation: J. Alexandre et al., Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients, J CL ONCOL, 18(3), 2000, pp. 562-573
Authors:
Negrier, S
Caty, A
Lesimple, T
Douillard, JY
Escudier, B
Rossi, JF
Viens, P
Gomez, F
Citation: S. Negrier et al., Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil, J CL ONCOL, 18(24), 2000, pp. 4009-4015
Authors:
Cowen, D
Houvenaeghel, G
Bardou, VJ
Jacquemier, J
Bautrant, E
Conte, M
Viens, P
Largillier, R
Puig, B
Resbeut, M
Maraninchi, D
Citation: D. Cowen et al., Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer, INT J RAD O, 47(2), 2000, pp. 305-312
Authors:
Bertucci, F
Viens, P
Delpero, JR
Bardou, VJ
Faucher, C
Houvenaeghel, G
Maraninchi, D
Citation: F. Bertucci et al., High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advancedovarian carcinoma: long-term results, BONE MAR TR, 26(1), 2000, pp. 61-67
Authors:
Gravis, G
Viens, P
Vey, N
Blaise, D
Stoppa, AM
Olive, D
Maraninchi, D
Citation: G. Gravis et al., Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers, ANTICANC R, 20(5C), 2000, pp. 3987-3991
Authors:
Genre, D
Viens, P
Gravis, G
Bertucci, F
Cowen, D
Novakovitch, G
Dermeche, S
Chabannon, C
Oziel-Taieb, S
Camerlo, J
Houvenaeghel, G
Jacquemier, J
Maraninchi, D
Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040
Authors:
Jacquemier, J
Mathoulin-Portier, MP
Valtola, R
Charafe-Jauffret, E
Geneix, J
Houvenaeghel, G
Puig, B
Bardou, VJ
Hassoun, J
Viens, P
Birnbaum, D
Citation: J. Jacquemier et al., Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3, INT J CANC, 89(1), 2000, pp. 69-73
Authors:
Lotz, JP
Lhomme, C
Pautier, P
Couteau, C
Gligorov, J
Alexandre, J
Selle, F
Izrael, V
Maraninchi, D
Viens, P
Citation: Jp. Lotz et al., High-dose chemotherapy in ovarian adenocarcinoma, B CANCER, 87(1), 2000, pp. 63-69
Authors:
Vey, N
Blaise, D
Lafage, M
Olive, D
Viens, P
Baume, D
Camerlo, J
Stoppa, AM
Gabus, R
Brandely, M
Hercend, T
Maraninchi, D
Citation: N. Vey et al., Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients, J IMMUNOTH, 22(2), 1999, pp. 175-181
Authors:
Chabannon, C
Novakovitch, G
Blache, JL
Olivero, S
Camerlo, J
Genre, D
Maraninchi, D
Viens, P
Citation: C. Chabannon et al., The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell (R) technology, HEM CELL TH, 41(2), 1999, pp. 78-81